SIC
BDTX icon

Salem Investment Counselors’s Black Diamond Therapeutics BDTX Stock Holding History

Salem Investment Counselors’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$177 – 1113
2023
Q2 		$177 Hold
35
– – ﹤0.01% 1119
2023
Q1 		$67 Hold
35
– – ﹤0.01% 1099
2022
Q4 		$63 Hold
35
– – ﹤0.01% 1075
2022
Q3 		$0 Hold
35
– – ﹤0.01% 1041
2022
Q2 		$0 Hold
35
– – ﹤0.01% 1071
2022
Q1 		$0 Hold
35
– – ﹤0.01% 1007
2021
Q4 		$0 Hold
35
– – ﹤0.01% 1070
2021
Q3 		$0 Hold
35
– – ﹤0.01% 970
2021
Q2 		$0 Buy
+35
New +$692 ﹤0.01% 903

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salem Investment Counselors's BDTX Position: Q3 2023 in Review

Salem Investment Counselors sold out of Black Diamond Therapeutics (BDTX) in Q3 2023, closing a stake of 35 shares — an estimated $177 sold.

Salem Investment Counselors first reported a position in BDTX in Q2 2021 and held it in 9 quarters. The position peaked at $177 in Q2 2023. 73 funds tracked by Wall St. Rank hold BDTX as of Q3 2023.

  • Salem Investment Counselors reported no remaining Black Diamond Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 35 Black Diamond Therapeutics shares in Q3 2023, an estimated $177.
  • Salem Investment Counselors first reported a position in Black Diamond Therapeutics in Q2 2021 and held it in 9 quarters.
  • Salem Investment Counselors's Black Diamond Therapeutics position peaked at $177 in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.